Martin Lord

6PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsVeterinary virologyCellular immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 18, 2024
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.

Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord

|Apr 06, 2023
Epitopes Displayed in a Cyclic Peptide Scaffold Bind SARS-COV-2 Antibodies.

Camilla Eriksson, Sunithi Gunasekera, Taj Muhammad

|Sep 30, 2021
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses.

Sara M Mangsbo, Sebastian Havervall, Ida Laurén

|Aug 30, 2021
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Sebastian Havervall, Henry Ng, August Jernbom Falk

|Jul 02, 2021
Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade.

Mohamed Eltahir, Johan Isaksson, Johanna Sofia Margareta Mattsson

Pageof 1